Peak oxygen consumption or VO2 was improved in all of the kids

The use of the active ingredient of erectile dysfunction for Viagra has been shown to improve the peak oxygen consumption in children suffering from Pulmonary Arterial Hypertension. The research which was submitted at the Annual Congress of the European Respiratory Society in Vienna, Austria is a big step forward in the treatment of Pulmonary Arterial Hypertension and gives more information on exactly how and why Sildenafil is effective in treating patients with this condition.

Peak oxygen consumption or VO2 was improved in all of the kids taking part in the study and who were given different doses depending on their weight. The use of Viagra has drastically improved the lives of hundreds of children around the globe who would not otherwise be able to live normally.

The study which was called The walk-Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy was also designed to look at children suffering from pulmonary hypertension who were also suffering from Sickle Cell Disease, however there were safety problems when giving the Sildenafil to the children with Sickle Cell Disease and so this part of the study was discontinued.

The use of Viagra opens up not just the penile artery to treat erectile dysfunction in men but also many other arteries in the human body which means that it has many different applications to treat both men and women. Ongoing research with Viagra’s active ingredient Sildenafil should lead to other treatments apart from the existing Revatio which is already being marketed by Pfizer to treat PAH. While men with heart problems should not use Viagra at present, some scientists are of the opinion that it could prevent heart attacks and strokes.

Over 230 children took part in this study which was led by Professor Robyn Barst from the Department of Medicine at the University of Pittsburgh in Pennsylvania.